Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome (Q37832696)

24 August 2017

1 reference

title

Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome (English)

1 reference

24 August 2017

arterial hypertension

0 references

1 reference

0 references

Elisabeth A Lambert

1

1 reference

PubMed ID

21271362

24 August 2017

Gavin W Lambert

series ordinal

2

1 reference

24 August 2017

1 June 2011

1 reference

Current Hypertension Reports

24 August 2017

1 reference

24 August 2017

13

1 reference

24 August 2017

3

1 reference

24 August 2017

244-248

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-011-0186-y

24 August 2017

0 references

cites work

Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Psychological stress and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Chronic stress at work and the metabolic syndrome: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Modulation of catecholamine-synthesizing enzymes in the rat heart by repeated immobilization stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Contribution of job control and other risk factors to social variations in coronary heart disease incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Neuroendocrine abnormalities in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Hostility and urine norepinephrine interact to predict insulin resistance: the VA Normative Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Psychosocial stress and 13-year BMI change among blacks: the Pitt County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Psychosocial stress and change in weight among US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Perceived stress and weight gain in adolescence: a longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Depression and anxiety among US adults: associations with body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Hypercortisolemic depression is associated with the metabolic syndrome in late-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Depressive symptoms and change in abdominal obesity in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Associations between anxiety, depression, and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Mediators of sympathetic activation in metabolic syndrome obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Sympathetic overdrive and cardiovascular risk in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Changes in plasma lipids with psychosocial stress are related to hypertension status and the norepinephrine stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Single-unit analysis of sympathetic nervous discharges in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Autonomic contribution to blood pressure and metabolism in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Renal sympathetic-nerve ablation for uncontrolled hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0186-Y

Firing properties of single muscle vasoconstrictor neurons in the sympathoexcitation associated with congestive heart failure

21 January 2018

1 reference

12 December 2020

The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.

1 reference

12 December 2020

Sympathetic neural activation in visceral obesity

1 reference

12 December 2020

Adrenergic and reflex abnormalities in obesity-related hypertension

1 reference

12 December 2020

The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension

1 reference

12 December 2020

Gender differences in sympathetic nervous activity: influence of body mass and blood pressure

1 reference

12 December 2020

Neural mechanisms in human obesity-related hypertension

1 reference

12 December 2020

Sympathetic activation in obese normotensive subjects

1 reference

12 December 2020

10.1007/S11906-011-0186-Y

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21271362